Hypoprothrombinemia and Hemorrhage Associated with Cholestyramine Therapy
Abstract
A 57-year-old woman being treated with cholestyramine developed hypoprothrombinemic hemorrhage. Dietary supplements of fat-soluble vitamins should be used routinely in every patient given the drug on a long-term basis.
Article and Author Information
-
▸From the Department of Medicine, Presbyterian Hospital, Pacific Medical Center, San Francisco, Calif.
-
▸Requests for reprints should be addressed to Martin Brotman, M.D., 655 Sutter St., San Francisco, Calif. 94102
RSS Feeds









